Gold Kelly bought XFOR
July 1, 2026 · Form 4 insider transaction
Gold Kelly bought 110,000 shares of X4 Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
110,000
Price
$0.00
Total value
N/A
InsiderGold Kelly
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 1, 2026
Shares owned after110,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest in full on the one-year anniversary of the grant date, subject to the Reporting Person continuing to provide services through such date.